IRAK-M regulation and function in host defense and immune homeostasis

Antigen presenting cells (APCs) of the innate immune system sense a wide range of pathogens via pattern recognition receptors (PRRs). Engagement of certain PRRs can induce production of pro-inflammatory mediators that facilitate effective clearance of pathogen. Toll-like receptors (TLRs) are a well...

Full description

Bibliographic Details
Main Authors: Leah L.N. Hubbard, Bethany B. Moore
Format: Article
Language:English
Published: MDPI AG 2010-06-01
Series:Infectious Disease Reports
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/idr/article/view/1850
id doaj-6af5879a67a645198de73d2c4474e9f7
record_format Article
spelling doaj-6af5879a67a645198de73d2c4474e9f72021-01-02T12:13:35ZengMDPI AGInfectious Disease Reports2036-74302036-74492010-06-0121e9e910.4081/idr.2010.e91208IRAK-M regulation and function in host defense and immune homeostasisLeah L.N. Hubbard0Bethany B. Moore1University of MichiganUniversity of MichiganAntigen presenting cells (APCs) of the innate immune system sense a wide range of pathogens via pattern recognition receptors (PRRs). Engagement of certain PRRs can induce production of pro-inflammatory mediators that facilitate effective clearance of pathogen. Toll-like receptors (TLRs) are a well described group of PRRs that belong to the TLR/Interleukin-1 receptor (IL-1R) superfamily. However, TLR/IL-1R induction of pro-inflammatory mediators must be regulated to prevent excessive inflammation and tissue damage. One molecule of recent interest that is known to inhibit TLR/IL-1R signaling is interleukin-1 receptor associated kinase (IRAK)-M, also known as IRAK-3. IRAK-M is expressed in a number of immune and epithelial cells types, and through its inhibition of pro-inflammatory cytokine production, IRAK-M can regulate immune homeostasis and tolerance in a number of infectious and non-infectious diseases. Furthermore, use of IRAK-M deficient animals has increased our understanding of the importance of IRAK-M in regulating immune responsiveness to a variety of pathogens. Although IRAK-M expression is typically induced through TLR signaling, IRAK-M can also be expressed in response to various endogenous and exogenous soluble factors as well as cell surface and intracellular signaling molecules. This review will focus on clinical scenarios in which expression of IRAK-M is beneficial (as in early sepsis) and those situations where IRAK-M expression is harmful to the host (as in cancer and following bone marrow transplant). There is strong rationale for therapeutic targeting of IRAK-M for clinical benefit. However, effective targeting will require a greater understanding of the transcriptional regulation of this gene.http://www.pagepress.org/journals/index.php/idr/article/view/1850sepsis, immune regulation, inflammation
collection DOAJ
language English
format Article
sources DOAJ
author Leah L.N. Hubbard
Bethany B. Moore
spellingShingle Leah L.N. Hubbard
Bethany B. Moore
IRAK-M regulation and function in host defense and immune homeostasis
Infectious Disease Reports
sepsis, immune regulation, inflammation
author_facet Leah L.N. Hubbard
Bethany B. Moore
author_sort Leah L.N. Hubbard
title IRAK-M regulation and function in host defense and immune homeostasis
title_short IRAK-M regulation and function in host defense and immune homeostasis
title_full IRAK-M regulation and function in host defense and immune homeostasis
title_fullStr IRAK-M regulation and function in host defense and immune homeostasis
title_full_unstemmed IRAK-M regulation and function in host defense and immune homeostasis
title_sort irak-m regulation and function in host defense and immune homeostasis
publisher MDPI AG
series Infectious Disease Reports
issn 2036-7430
2036-7449
publishDate 2010-06-01
description Antigen presenting cells (APCs) of the innate immune system sense a wide range of pathogens via pattern recognition receptors (PRRs). Engagement of certain PRRs can induce production of pro-inflammatory mediators that facilitate effective clearance of pathogen. Toll-like receptors (TLRs) are a well described group of PRRs that belong to the TLR/Interleukin-1 receptor (IL-1R) superfamily. However, TLR/IL-1R induction of pro-inflammatory mediators must be regulated to prevent excessive inflammation and tissue damage. One molecule of recent interest that is known to inhibit TLR/IL-1R signaling is interleukin-1 receptor associated kinase (IRAK)-M, also known as IRAK-3. IRAK-M is expressed in a number of immune and epithelial cells types, and through its inhibition of pro-inflammatory cytokine production, IRAK-M can regulate immune homeostasis and tolerance in a number of infectious and non-infectious diseases. Furthermore, use of IRAK-M deficient animals has increased our understanding of the importance of IRAK-M in regulating immune responsiveness to a variety of pathogens. Although IRAK-M expression is typically induced through TLR signaling, IRAK-M can also be expressed in response to various endogenous and exogenous soluble factors as well as cell surface and intracellular signaling molecules. This review will focus on clinical scenarios in which expression of IRAK-M is beneficial (as in early sepsis) and those situations where IRAK-M expression is harmful to the host (as in cancer and following bone marrow transplant). There is strong rationale for therapeutic targeting of IRAK-M for clinical benefit. However, effective targeting will require a greater understanding of the transcriptional regulation of this gene.
topic sepsis, immune regulation, inflammation
url http://www.pagepress.org/journals/index.php/idr/article/view/1850
work_keys_str_mv AT leahlnhubbard irakmregulationandfunctioninhostdefenseandimmunehomeostasis
AT bethanybmoore irakmregulationandfunctioninhostdefenseandimmunehomeostasis
_version_ 1724354568220835840